Association of PSP phenotypes with survival: A brain-bank study

Parkinsonism Relat Disord. 2021 Mar:84:77-81. doi: 10.1016/j.parkreldis.2021.01.015. Epub 2021 Feb 2.

Abstract

Introduction: The MDS-PSP criteria expand the phenotypic spectrum of PSP by adding to Richardson's syndrome (PSP-RS) other presentations such as PSP-parkinsonism (PSP-P), PSP-pure-gait-freezing (PSP-PGF), PSP-speech-language (PSP-SL), PSP-frontal (PSP-F), PSP-postural-instability (PSP-PI) and PSP-corticobasal-syndrome (PSP-CBS). Evidence about the prognostic differences between PSP phenotypes is scarce and focused on PSP-RS vs. non-PSP-RS. Using a brain-bank cohort we assessed PSP survival not only in PSP-RS vs. non-PSP-RS, but also in PSP-RS + cortical vs. subcortical phenotypes. Besides, we assessed sensitivity and specificity of the MDS-PSP criteria in of PSP and other degenerative parkinsonisms.

Methods: We retrospectively applied the MDS-PSP diagnostic criteria to 32 definite PSP cases and 30 cases with other degenerative parkinsonian syndromes (Parkinson's disease [PD; n = 11], multiple system atrophy [MSA; n = 11], corticobasal degeneration [CBD; n = 8]). We conducted survival statistics in neuropathologically confirmed PSP cases considering PSP-RS vs. non-PSP-RS and PSP-RS + PSP-cortical (PSP-F + PSP-SL + PSP-CBS) vs. PSP-subcortical (PSP-P + PSP-PGF) phenotypes. We also adjusted survival analyses for PSP tau scores.

Results: Diagnostic sensitivity was 100% and specificity ranged from 47% to 87% when excluding cases that met the "suggestive of PSP" definition early in their disease course but with other clinical features better matching with a non-PSP pathological diagnosis. Survival was significantly shorter in PSP-RS vs. non-PSP-RS cases, but it was more markedly shorter in PSP-RS + PSP-cortical vs. PSP-subcortical, independently of PSP tau scores, which were not associated with survival.

Conclusions: PSP-subcortical phenotypes appear to have longer survival than PSP-RS and cortical phenotypes. This might be of prognostic relevance when informing patients upon clinical diagnosis.

Keywords: PSP; PSP-P; PSP-PGF; Phenotype; Prognosis; Richardson's syndrome; Survival.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Cohort Studies
  • Female
  • Humans
  • Male
  • Middle Aged
  • Parkinsonian Disorders / classification
  • Parkinsonian Disorders / diagnosis*
  • Parkinsonian Disorders / mortality*
  • Parkinsonian Disorders / physiopathology
  • Phenotype
  • Practice Guidelines as Topic
  • Prognosis
  • Retrospective Studies
  • Sensitivity and Specificity
  • Supranuclear Palsy, Progressive / classification
  • Supranuclear Palsy, Progressive / diagnosis*
  • Supranuclear Palsy, Progressive / mortality*
  • Supranuclear Palsy, Progressive / physiopathology
  • Survival Analysis
  • Tissue Banks